0001209191-11-044646.txt : 20110817 0001209191-11-044646.hdr.sgml : 20110817 20110817162923 ACCESSION NUMBER: 0001209191-11-044646 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110816 FILED AS OF DATE: 20110817 DATE AS OF CHANGE: 20110817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parker Peter CENTRAL INDEX KEY: 0001495401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 111042806 MAIL ADDRESS: STREET 1: 1 KENDALL SQUARE STREET 2: B7102 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marina Biotech, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3830 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4259083600 MAIL ADDRESS: STREET 1: 3830 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-08-16 0 0000737207 Marina Biotech, Inc. MRNA 0001495401 Parker Peter 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 1 0 0 0 Marina Biotech, Inc. Common Stock 2011-08-16 4 J 0 40200 0.2389 D 84010 D As reported on a Form 4 filed on February 15, 2011, on February 11, 2011, certain stockholders of Marina Biotech, Inc. ("Marina") entered into a Transfer and Sale Agreement with Marina and the Reporting Person pursuant to which they agreed to transfer a total of 116,253 shares of Marina Common Stock that they had received as merger consideration in connection with the merger of Cequent Pharmacueticals, Inc. ("Cequent") with and into Marina to the reporting person as consideration for services rendered by the Reporting person to Cequent. On August 15, 2011, pursuant to the Transfer and Sale Agreement, the shares were transferred to the Reporting Person and on August 16, 2011, 40,200 shares were sold to cover the Reporting Person's tax obligations, which sale is reported on this Form 4. /s/Peter S. Garcia Attorney in Fact 2011-08-17